# PsychoContext V8 — CBDNA Research and Technical Specification

**Version:** 2.0-proposed | **Status:** Core-engine architecture approved by owner prompt; operational constructs and mathematics remain unvalidated

## 1. Definition, purpose and boundary

Cognitive Behavioral DNA (CBDNA) is the independent core engine intended to represent interconnected, multidimensional, contextual, dynamic and longitudinal cognitive/behavioral patterns across sources. It organizes evidence and candidate patterns to support clinician formulation and research. It is not a diagnosis, personality type, innate essence, universal score, psychometric instrument, treatment selector, safety classifier or autonomous clinical decision-maker. It does not replace validated measures or clinician judgment.

“Core engine” is an architectural/product decision, not a claim that a validated model already exists. Maturity proceeds from provenance ledger (L1) to reviewed descriptive trajectories (L2), evidence-supported analytic models (L3) and independently validated research-grade models (L4). See 15.

## 2. Feature lifecycle and epistemic types

Use immutable source classes: patient self-report; clinician-observed behavior; clinician interpretation; authorized instrument result; behavioral record; AI-generated hypothesis; research-derived finding; validated construct measurement. A record cannot change class by editing a label. Promotion to an approved construct requires a separate evidence/approval record. Distinguish adaptive, compensatory, context-dependent and potentially maladaptive patterns; none is pathology by default.

Each candidate feature definition specifies construct/operational meaning, inclusion/exclusion boundaries, observable indicators, measurement level, expected timeframe, population/language, method, permitted use, evidence, limitations, missing-data rules, safety implications and maturity level.

## 3. Candidate mathematical families — evaluation, not selection

No universal model is imposed. Select per construct, purpose, measurement level and available data only after evaluation.

| Method family | Possible scientific purpose | Assumptions/data | Limitations/bias and interpretability | Arabic/population and validation needs | Permitted maturity |
|---|---|---|---|---|---|
| Descriptive longitudinal summaries / event timelines | Display observed change without latent inference | Comparable observations, known timestamps/context | Missingness, recall and measurement changes; relatively interpretable | Test dialect/translation metadata and culturally relevant event coding | L1–L2 after provenance tests |
| Multidimensional latent-variable models (e.g., factor/IRT families) | Estimate latent dimensions from multiple indicators | Appropriate item/measurement model, sufficient sample, invariance assumptions | Model misspecification, local dependence, differential item functioning, opaque score if misused | Require language and population measurement invariance and sample justification | L4 research; never default clinical score |
| State-space / growth / mixed-effects longitudinal models | Estimate within-person change and population trajectories | Repeated comparable measures; missingness assumptions; temporal design | Confounding, sparse time points, nonstationarity, individual-to-population errors | Need dialect/population subgroup evaluation and external replication | L3–L4 research until validated |
| Bayesian/probabilistic inference | Represent uncertainty and update hypotheses from evidence | Defensible priors/likelihoods, calibrated observations | Prior sensitivity, false precision, calibration drift; explanations needed | Validate calibration by language/population; avoid unreviewed risk probabilities | L3 research/decision support only after validation |
| Graph-based relationships / knowledge graphs | Represent relations among constructs, contexts and evidence | Curated, typed relations and provenance | Graph edges can be mistaken for causality; coverage bias | Validate relation semantics and source coverage in Arabic research | L1 curated graph; advanced inference L3–L4 |
| Temporal sequence/pattern mining | Discover candidate patterns over events | Sufficient longitudinal event density, stable coding | Spurious patterns, leakage, multiple testing, privacy risk | Assess cultural/event coding differences and replicability | Research only, L4 |
| Contextual/multilevel models | Examine environment/person interactions | Valid context measures, enough clusters/time and theory | Ecological fallacy, confounding, unfair subgroup effects | Local context variables need validity and lawful collection | Research only unless purpose-specific evidence |
| Hybrid combination | Combine descriptive, latent, temporal, graph or probabilistic components | Each component validated; explicit interface and error propagation | Complexity, cumulative bias, reduced explainability | End-to-end language/population and fairness evaluation | L4 only unless bounded subcomponent has evidence |

For every proposed method document purpose, assumptions, required data, measurement level, limitations, bias, interpretability, Arabic suitability, validation requirements and permitted use. Model choice must follow scientific evaluation, not preference.

## 4. Provenance, context, time and uncertainty

Every feature observation records pseudonymous subject reference; source/source span; author or model/provider; method and version; event/recorded time; temporal window; context record; consent purpose; raw value/unit; uncertainty/missingness; review state; lineage/transform version; and retention class. Preserve contradictory observations as concurrent evidence; do not select a winner by recency or AI confidence. Context explains interpretation; it does not alter raw validated scores.

## 5. Research transformation from patient memory

Owner-approved process: Patient Clinical Memory → Candidate Pattern Extraction → AI-assisted Analysis → Specialist Review → Scientific/Methodological Validation → appropriate de-identification and Ethics Review → Approved Research Knowledge → Versioned Repository. Patient record remains protected and separate. No one case establishes a general finding; no automatic psychometric item or scoring change. Research protocol defines question, population, sampling, data minimization, methods, uncertainty, bias, replication and publication/rollback controls. See 09/14/16.

## 6. Clinical integration boundary

CBDNA can provide a provenance-rich contextual display to an authorized clinician at approved maturity. It cannot diagnose, prescribe, determine safety, raise/lower risk, recommend emergency response autonomously, or initiate/change a treatment plan. No feature becomes part of a signed formulation without clinician review and attribution. Clinical safety workflow remains available if CBDNA, AI or retrieval fails (RTM-14/28).

## 7. Validation gates

Define construct and intended use; expert/community content review; operationalization; feasibility and missingness; reliability appropriate to feature; convergent/discriminant evidence; temporal stability/change validity; measurement invariance/fairness; calibration where probabilistic; external replication; Arabic language/dialect evaluation; privacy/reidentification; and prospective impact evaluation before decision support. Ethics/legal review and consent are required for research use. A single clinician approval or model agreement rate is not validation.

## 8. Release states and stop conditions

- L1 design/provenance ledger: no inferred clinical conclusion.
- L2 descriptive trends: comparable evidence, clear uncertainty and clinician review.
- L3 analytic candidates: model-specific validation and monitored use, advisory only.
- L4 research-grade: approved protocol, independent evaluation and bounded intended use.

Stop if lineage is lost, context is hidden, model is irreproducible, contradictory evidence is suppressed, bias/reidentification risk is unacceptable or UI implies person-level certainty. Open construct/measure decisions remain owner/scientific review items; no DNA score is defined.

## Proposed clarification — contextual integration across independent measures (pending approval)

CBDNA may organize evidence-informed relationships, co-occurring patterns and temporal changes among distinct instrument results, observations and context to support clinician-authored formulation. Preserve each original result, source, version, language, administration date, timeframe and limitation. Clearly distinguish association, co-occurrence, clinician interpretation and causality. Such contextual synthesis does not authorize raw-score aggregation, instrument substitution, causal inference from correlation, or score adjustment. Longitudinal comparability requires compatible form/version, language, administration method, population and recall period, or a validated crosswalk; otherwise block comparison or label it non-comparable. AI-generated links remain hypotheses for qualified human review.
